Larry Edwards - Jan 31, 2022 Form 4 Insider Report for LA JOLLA PHARMACEUTICAL CO (LJPC)

Role: Chief Executive Officer
Signature: /s/ Larry Edwards
Stock symbol: LJPC
Transactions as of: Jan 31, 2022
Transactions value $: $16,411
Form type: 4
Date filed: 2/2/2022, 06:21 PM
Previous filing: Jan 19, 2022
Next filing: Feb 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LJPC	Common Stock	Award	$16.4K	+4.17K	+67.94%	$3.94	10.3K	Jan 31, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LJPC	Employee Stock Option (Right to Buy)	Award	$0	+4.17K		$0.00	4.17K	Jan 31, 2022	Common Stock	4.17K	$4.63	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired on 1/31/2022 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2	The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of the grant date and then vest and become exercisable ratably on a monthly basis over the next three years.